MicroRNA-455 suppresses non-small cell lung cancer through targeting ZEB1

Ying-Jie Li1, Chen Ping1, Jian Tang1

  • 1Department of Cardio-Thoracic Surgery, First Affiliated Hospital of Chinese PLA General Hospital, Beijing, 100048, China.

Insights

MicroRNA-455 (miRNA-455) is downregulated in non-small cell lung cancer (NSCLC), suppressing tumor growth and spread. Restoring miRNA-455 acts as an anti-oncogene by targeting ZEB1, offering a potential therapeutic strategy for NSCLC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • MicroRNA-455 (miRNA-455) is implicated in human carcinogenesis but its role in non-small cell lung cancer (NSCLC) is not fully understood.
  • Dysregulation of microRNAs is a hallmark of cancer development and progression.

Purpose of the Study:

  • To investigate the expression levels of miRNA-455 in NSCLC.
  • To elucidate the functional role of miRNA-455 in NSCLC cell proliferation, migration, and invasion.
  • To identify the molecular targets of miRNA-455 in NSCLC.

Main Methods:

  • Real-time PCR to quantify mature miRNA-455 expression in NSCLC tissues and cell lines.
  • Gain-of-function studies using miRNA-455 mimics to assess effects on cell proliferation, migration, and invasion.
  • Reporter assays to confirm direct binding of miRNA-455 to the 3'UTR of ZEB1.
  • Western blotting to evaluate ZEB1 protein levels.
  • Correlation analysis between miRNA-455 and ZEB1 expression in NSCLC tissues.

Main Results:

  • miRNA-455 expression was significantly downregulated in NSCLC cell lines and tissues compared to normal controls.
  • Overexpression of miRNA-455 suppressed NSCLC cell proliferation, migration, and invasion.
  • miRNA-455 directly targets the 3' untranslated region (3'UTR) of ZEB1, leading to reduced ZEB1 protein expression.
  • ZEB1 overexpression reversed the suppressive effects of miRNA-455 on NSCLC cell malignancy.
  • A significant inverse correlation was observed between ZEB1 and miRNA-455 expression in NSCLC tissues.

Conclusions:

  • miRNA-455 functions as an anti-oncogene in non-small cell lung cancer.
  • The anti-oncogenic activity of miRNA-455 in NSCLC is mediated through the downregulation of ZEB1.
  • miRNA-455 represents a potential therapeutic target for non-small cell lung cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

12.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.3K